Drugs / Diphtheria/Tetanus Vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01339000 | Apr 2011 → Apr 2016 | breast cancer, colon carcinoma, urinary bladder cancer | National Cancer Institute (NCI) | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Diphtheria/Tetanus Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01339000 ↗ |
| Modality | Vaccine | “Diphtheria/Tetanus Vaccine will be administered according to the random schedule per protocol.” NCT01339000 ↗ |